Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

THE BEAUTY HEALTH COMPANY

(SKIN)
  Report
Delayed Nasdaq  -  04:00 2022-11-28 pm EST
9.940 USD   +0.10%
11/23Goldman Sachs Adjusts Beauty Health's Price Target to $19 From $22, Keeps Buy Rating
MT
11/15Beauty Health Co : Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Financial Statements and Exhibits (form 8-K)
AQ
11/15The Beauty Health Company Enters into an Amended and Restated Credit Agreement with JPMorgan Chase Bank
CI
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news
Days
:
Hours
:
Minutes
:
Seconds

BeautyHealth plans to double size of business by 2025

09/15/2022 | 07:15am EST

Sept 15 (Reuters) - BeautyHealth said on Thursday it was planning to double the size of its business by 2025, building on demand for its flagship HydraFacial skin treatment devices as affluent customers drive up skincare sales.

Inflation-hit consumers are treating themselves to smaller luxuries such as beauty products and services, keeping alive a renewed focus on health and wellness that was fanned by the pandemic.

In its first unveiling of a long-term target, BeautyHealth forecast net sales of $600 million to $700 million in 2025, up from $260.1 million last year.

"BeautyHealth sits at this really exciting intersection of large and growing categories: beauty, aesthetics, wellness and health," Chief Executive Officer Andrew Stanleick told Reuters.

"What we're benefiting from is real societal shifts in beauty, health and wellness in all countries, which has been accelerated by COVID."

Apart from the resilient nature of beauty demand during economic downturns, BeautyHealth also benefits from a relatively affluent customer base with an average annual household income of $94,000.

The company has penetrated 5% of the around 500,000 medical, spa and hospitality establishments in its 16 direct markets, and it plans to enter more with its HydraFacial delivery systems.

Brand awareness and acquiring complementary businesses are also areas of focus for the firm.

Long Beach, California-based BeautyHealth has already partnered with hotel operator Marriott International, cosmetics retailer Ulta Beauty and healthcare chain Advanced Dermatology and Cosmetic Surgery.

On Thursday, the company said its tie-up with LVMH-owned beauty chain Sephora will next year expand to the Asia-Pacific, a key growth driver for skincare firms.

It also expects to triple its adjusted core earnings (EBITDA) margin in 2025 to between 25% and 30%, compared with 12.6% last year. (Reporting by Praveen Paramasivam in Bengaluru; Editing by Devika Syamnath)


ę Reuters 2022
Stocks mentioned in the article
ChangeLast1st jan.
LVMH MOËT HENNESSY LOUIS VUITTON SE 0.53% 702.4 Real-time Quote.-3.89%
MARRIOTT INTERNATIONAL, INC. -2.24% 158.89 Delayed Quote.-1.64%
THE BEAUTY HEALTH COMPANY 0.10% 9.94 Delayed Quote.-58.86%
ULTA BEAUTY, INC. 1.98% 457.24 Delayed Quote.10.89%
All news about THE BEAUTY HEALTH COMPANY
11/23Goldman Sachs Adjusts Beauty Health's Price Target to $19 From $22, Keeps Buy Rating
MT
11/15Beauty Health Co : Entry into a Material Definitive Agreement, Creation of a Direct Financ..
AQ
11/15The Beauty Health Company Enters into an Amended and Restated Credit Agreement with JPM..
CI
11/11BeautyHealth to Participate in Stifel 2022 Healthcare Conference
BU
11/10Beauty Health Signs Accelerated Stock Buyback Deal With JP Morgan
MT
11/10Beauty Health Co : Regulation FD Disclosure, Other Events, Financial Statements and Exhibi..
AQ
11/10BeautyHealth Enters Into $100 Million Accelerated Share Repurchase Agreement
BU
11/10North American Morning Briefing: Crucial -3-
DJ
11/09BEAUTY HEALTH CO Management's Discussion and Analysis of Financial Condition and Resul..
AQ
11/09A good configuration for markets
MS
More news
Analyst Recommendations on THE BEAUTY HEALTH COMPANY
More recommendations
Financials (USD)
Sales 2022 363 M - -
Net income 2022 41,8 M - -
Net cash 2022 56,9 M - -
P/E ratio 2022 37,1x
Yield 2022 -
Capitalization 1 423 M 1 423 M -
EV / Sales 2022 3,76x
EV / Sales 2023 3,04x
Nbr of Employees 704
Free-Float 91,5%
Chart THE BEAUTY HEALTH COMPANY
Duration : Period :
The Beauty Health Company Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends THE BEAUTY HEALTH COMPANY
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 11
Last Close Price 9,94 $
Average target price 19,33 $
Spread / Average Target 94,5%
EPS Revisions
Managers and Directors
Andrew Stanleick President, Chief Executive Officer & Director
Liyuan Woo Chief Financial Officer & Executive Vice President
Brenton L. Saunders Executive Chairman
David Aquino Executive Vice President-Global Operations
Michael D. Capellas Independent Director
Sector and Competitors
1st jan.Capi. (M$)
THE BEAUTY HEALTH COMPANY-58.86%1 423
L'ORÉAL-15.41%194 914
KAO CORPORATION-6.89%18 711
SHISEIDO COMPANY, LIMITED-9.64%16 634
YUNNAN BOTANEE BIO-TECHNOLOGY GROUP CO.LTD-32.69%7 590
PROYA COSMETICS CO.,LTD.13.90%6 672